Press Releases

Press Releases

Share
Share
and/or
495 News Releases found
Yael David, PhD
Memorial Sloan Kettering Cancer Center Chemical Biologist Yael David Awarded 2024 Alfred P. Sloan Research Fellowship
Awarded annually since 1955, the Sloan Research Fellowships honor exceptional U.S. and Canadian researchers whose creativity, leadership, innovation, and research accomplishments make them stand out as the next generation of leaders.
Memorial Sloan Kettering Launches Bilingual Campaign Promoting Screenings in the Hispanic Community
Memorial Sloan Kettering Cancer Center Launches Bilingual Campaign Promoting Screenings in the Hispanic Community
On World Cancer Day, MSK Launches Public-Service Announcement ‘Late,’ Emphasizing the Urgency and Power of Routine Cancer Screenings
Cycle for Survival to Kick Off 2024 Events Nationwide
Cycle for Survival to Kick Off 2024 Events Nationwide
Cycle for Survival, the official rare cancer fundraising event of Memorial Sloan Kettering Cancer Center (MSK), will begin its 2024 signature team stationary-cycling events. As the founding partner of Cycle for Survival, Equinox will have its instructors leading high-energy rides across the country. 100% of the funds raised go directly to rare cancer research at MSK.
MSK Awards & Appointments January 2023
MSK Awards & Appointments January 2024
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments:Selwyn Vickers Elected to the Fellows of the American Asso...
Fred's Team runners
Fred’s Team Sets Historic $8 Million Fundraising Record For Cancer Research
The Fred’s Team community reached a new milestone during the 2023 season by raising $8 million. 100% of the funds raised will go directly to cancer research at Memorial Sloan Kettering Cancer Center.
Selwyn M. Vickers, MD
Memorial Sloan Kettering Cancer Center President and CEO, Selwyn M. Vickers, MD, Elected to the Fellows of the American Association for Cancer Research (AACR) Academy
Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce Selwyn M. Vickers, MD, President and CEO of MSK, is among 30 international scientific leaders elected today to the prestigious Fellows of the American Association for Cancer Research (AACR) Academy class of 2024.
MSK Awards & Appointments January 2023
MSK Awards & Appointments December 2023
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments:Omar Abdel-Wahab Received the William Dameshek Prize from ...
Memorial Sloan Kettering Cancer Center Announces Landmark $400 Million Gift From Citadel Founder and CEO Kenneth C. Griffin and David Geffen, Founder, the David Geffen Foundation
Memorial Sloan Kettering Cancer Center Announces Landmark $400 Million Gift From Citadel Founder and CEO Kenneth C. Griffin and David Geffen, Founder of the David Geffen Foundation
Memorial Sloan Kettering Cancer Center (MSK) today announced the largest single donation in its nearly 150-year history, a $400 million gift from Kenneth C. Griffin, Founder and Chief Executive Officer of Citadel and Founder of Griffin Catalyst, and David Geffen, Founder of The David Geffen Foundation. It will serve as the cornerstone of MSK’s foundation for the future and will be instrumental in extending the power and potential of cancer care and treatment to people across New York and around the world as MSK continues to advance cutting-edge research and new cancer treatments.
MSK Awards & Appointments January 2023
MSK Awards & Appointments November 2023
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during The American Society of Hematology (ASH) annual meeting.
ASH 2023: Memorial Sloan Kettering Cancer Center Experts Featured at The American Society of Hematology Annual Meeting
Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during The American Society of Hematology (ASH) annual meeting, December 9-12 in San Diego, CA.